Modulation of cisPlatin cytotoxicity by interleukin-1α and resident tumor macrophages

Biotherapy

Volumn 10, Issue 2, 1997, Pages 129-137

  Braunschweiger, Paul G ^a,b,c,d,e   Basrur, Vathsala S ^a   Cameron, Dayna ^a   Sharpe, Laura ^a   Santos, Octavio ^a   Perras, James P ^a   Sevin, Bernd Uwe ^a   Markoe, Arnold M ^a  

^a Department of Radiation Oncology ^*  (United States)

^b Division of Gynecology   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Cisplatin; Drug resistance; Il 1 ; Tumor macrophages

Indexed keywords

CISPLATIN; HYDROXYL RADICAL; INTERLEUKIN 1ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMOSENSITIVITY; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG SYNERGISM; FEMALE; HYDROGEN PEROXIDE; INTERLEUKIN-1; KINETICS; MACROPHAGES; MICE; MICE, INBRED C3H; OXIDANTS; TUMOR CELLS, CULTURED;

EID: 0030774926     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02678540     Document Type: Article

References (36)

1. Andersen CM, Buzaid AC, Ali-Osman, F., Braunschweiger, PG, Grimm, EA Biochemotherapy in the treatment of Advanced Melanoma: Clincal results and Potential Mechanisms of Antitumor Activity. In: Hortobagyi GN and Khayat D, eds. Cancer Chemotherapy, Cambridge MA: Blackwell Science Inc., IN PRESS.
2. Neta R, Vogel SN, Plocinski JM, Tare NS, Benjamin W, Chizzonite R, Pilcher M. In Vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6. Blood 1990; 76: 57-62.
3. Braunschweiger P, Johnson CS, Kumar N, Ord V, Furmanski P. Antitumor effects of recombinant human Interleukin la in RIF-1 and PancO2 solid tumors. Cancer Res. 1988; 48: 6011-6.
4. Constantinidis I, Braunschweiger P, Wehrle J, Kumar N, Johnson CS, Furmanski P, Glickson JD. 31P-Nuclear magnetic resonance studies of the effect of recombinant human Interleukin la on the bioenergetics of RIF-1 tumors. Cancer Res. 1989; 49: 6379-82.
5. Song CW, Lin J-C, Lyons JC. Antitumor effect of Interleukin1 in combination with hyperthermia. Cancer Res. 1993; 53: 324-8.
6. Braunschweiger PG, Kumar N, Constantinidis I, Wehrle JP, Glickson JD, Johnson CS, Furmanski P. Potentiation of interleukin la mediated antitumor effects by ketoconazole. Cancer Res. 1990; 50: 4709-17.
7. Braunschweiger PG, Basrur VS, Santos O, Markoe AM, Houdek PV, Schwade JG. Synergistic antitumor activity of cisPlatin and interleukin-1 in sensitive and resistant solid tumors. Cancer Res. 1993; 53: 1091-7.
8. Braunschweiger GP, Jones AS, Johnson SC, Furmanski P. Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human Interleukin la. Cancer Res. 1991; 51: 5454-60.
9. Braunschweiger PG, Jones SA, Johnson CS, Furmanski P. Interleukin-1 induced tumor pathophysiologies can be exploited with bio-reductive alkylating agents. Int J Radiât Biol 1991 ; 60: 369-72.
10. Teicher BA, Lazo JS and Sartorelli AC, Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 1981; 41: 73-81.
11. Chong YC, Heppner GH, Paul LA and Fulton AM, Macrophage mediated induction of DNA strand breaks in target cells. Cancer Res. 1989; 49: 6652-7.
12. Schraufstatter I, Hysolp PA, Jackson JH, Cochrane CG. Oxidant induced DNA damage of target cells. J of Clin. Invest. 1988; 82: 1040-50.
13. Spitz DR, Malcolm RR, Roberts RJ. Cytotoxicity and metabolism of 4-hydroxy-2-nonenal and 2-nonenal in H2O2resistant cell lines. Do aldchydic by-products of lipid peroxidation contribute to oxidative stress? Biochem J 1990; 267: 453-9.
14. Eckl PM, Ortner A, Esterbauer H. Genotoxic properties of 4hydroxyalkenals and analogous aldehydes. Mutation Research 1993; 290: 183-92.
15. Fu KK, DeGregorio MW, Phillips JW. Plasma and tumor concentrations of cisPlatin following intraperitoneal infusion or bolus injection with and without continuous low dose irradiation. NCI Monograph 1988; 6: 123-7.
16. Sevin BU, Peng ZL, Perras JP, Ganjei P, Penalver M, Averette HE. Application of an ATP-bioluminescence assay in human tumorchemosensitivity testing. GynOncol 1988; 31:191-204.
17. Freund M, Pick E. The mechanism of action of cytokines IX. The enzymatic basis of hydrogen peroxide production by lymphokine - activated macrophages. J. Immunol. 1986; 137: 1312-8.
18. Zar JH Biostatistical Analysis . Englewood Cliffs, N.J., Prentice Hall Inc., 1974
19. Johnson CS, Chang M-J, Yu W-D, Modzelewski RA, Grandis JR, Vlock DR, Furmanski P. Synergistic enhancement by interleukin-la of cisPlatin mediated antitumor activity in RIFtumor bearing C3H/HeJ mice. Can Chemother and Pharmacol 1993; 32: 339-46.
20. Grandis JR, Chang MJ, Yu WD, Johnson CS. Antitumor activity of interleukin-1 alpha and CisPlatin in a murine model system. Arch of Otolaryngol - Head & Neck Surgery 1995; 121: 197-200.
21. Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS. Potentiation by interleukin 1 alpha of CisPlatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Cancer Res. 1994; 54: 5380-6.
22. Surest) A, Sodhi A. Production of interleukin-1 and tumor necrosis factor by bone marrow-derived macrophages - Effect of cisPlatin and lipopolysaccharide. Immunol Letters 1991; 30: 93-100.
23. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RCJ. Tumor necrosis factor alpha as an automne and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res. 1993; 53: 1939-44.
24. Braunschweiger PG, Schiffer LM, Furmanski P. 1H-NMR relaxation times and water compartmentalization in experimental tumor models. Mag Reson Imaging. 1986; 4: 335-42.
25. Brown JM, White WC, Terada LS, Grosso MA, Shanley PL, Mulvin DW, Banerjee A, Whitman GJR Harken AH. Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Cell Biol 1990; 87: 5026-30.
26. White WC, Ghezzi P, Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor. Role of antioxidant enzymes and effect of cycloxygenase inhibitors. Biotherapy 1989; 1:361-7.
27. Basrur VS, Santos O, Perras JP, Sevin B-U, Braunschweiger PG. Acute Oxidant stress decreases cisPlatin resistance in murine and human tumor cells in vitro. Proc. AACR. 1993; 34: 402.
28. Begg AC, Stewart FA, Dewit L, Bartlink H. Interaction between cisPlatin and radiation in experimental rodent tumors and normal tissues. In: BT Hill and AS Bellamy (eds.), Antitumor Drug Radiation Interactions, vol, pp. 154-170. Boca Raton: CRC Press, 1990.
29. Holden S, Teicher BA, Ara G, Herman TS, Coleman CN. Enhancement of alkylating agent activity by SR4233 in FSallC murine fibrosarcoma. J Natl Cancer Instit 1992; 84: 187-93.
30. Hamilton TC, Winker MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, Ozols RF. Augmentation of adriamycin, Melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian carcinoma cell lines by buthione sulfoximine mediated glutathione depletion. Biochem Pharmacol 1985; 34: 2583-6.
31. Kelly SL, Basu A, Teicher B A, Hacker MP, Hamer H, Lazo JS. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 1988; 214: 1813-5.
32. Karin M, Imbra RJ, Heguy A and Wong G, interleukin-1 regulates metallothionein gene expression. Mol and Cell Biol 198S; 5:2866-9.
33. Shull S, Hcintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, Mossman BT. Differential regulation of antioxidant enzymes in response to oxidants. J of Biol Chem 1991; 266: 24398-403.
34. lijima Y, Fukushima T, Bhuiyan LA, Yamada T, Kosaka F, Satao JD. Synergistic and additive induction of metallothionein in Chang liver cells. A possible mechanism of marked Induction of metallothionein by stress. Febs 1990; 269: 218-20.
35. Dominguez I, Panneerselvam N, Escalza P, Natarajan AT, Cortes F. Adaptive response to radiation damage in human lymphocytes conditioned with hydrogen peroxide as measured by the cytokinesis-block micronucleus technique. Mutation Res 1993; 301: 135-41.
36. 2 concentration in rat brain after hyperoxic convulsions. Am J Physiol 1990; 69: 1761-6.